Kventiax SR 300 mg tablete s produljenim oslobađanjem
Name | Kventiax SR 300 mg tablete s produljenim oslobađanjem |
---|---|
Marketing Authorisation Number | HR-H-173044630 |
Active Substance | kvetiapinfumarat |
Composition | svaka tableta s produljenim oslobađanjem sadrži 300 mg kvetiapina u obliku kvetiapinfumarata |
Pharmaceutical Form | tableta s produljenim oslobađanjem |
Manufacturer | Krka d.d., Novo mesto, Novo Mesto, Slovenija |
Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
Marketing Authorisation Date | 17.07.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/19-02/168 |
Registration Number | 381-12-01/38-20-03 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ponovljivi recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | N05AH04 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |
Educational materials for healthcare professionals |
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2 |